VP, Strategic Operations and Corporate Affairs @ Keryx Biopharmaceuticals (April 2014 - January 2017)
VP, Investor Relations and Corporate Communications @ (September 2009 - April 2014)
VP, Corporate Communications @ Idenix (June 2004 - September 2009)
Sr. VP and General Manager West Coast Practice @ Euro RSCG Life/NRP (January 2001 - January 2003)
Director, Investor Relations @ (January 2000 - January 2001)
Public Relations Manager @ (January 1996 - January 1999)
Corporate Communications @ (January 1991 - January 1996)
Amy Sullivan Education
Bentley College - Elkin B. McCallum Graduate School of Business 1998-1998
Amy Sullivan Skills
Oncology
Lifesciences
Pharmaceutical Industry
Biotechnology
Clinical Development
Public Relations
Investor Relations
Biopharmaceuticals
Product Launch
Corporate Communications
Clinical Trials
Competitive Intelligence
Management
Neurology
Corporate Development
Cross-functional Team Leadership
Public Affairs
Strategy
Life Sciences
Amy Sullivan Summary
Amy Sullivan, based in Boston, MA, US, is currently a Chief Financial Officer at IO Biotech. Amy Sullivan brings experience from previous roles at TABA B.V., Kiadis Pharma and Keryx Biopharmaceuticals. Amy Sullivan holds a 1998 - 1998 Bentley College - Elkin B. McCallum Graduate School of Business. With a robust skill set that includes Oncology, Lifesciences, Pharmaceutical Industry, Biotechnology, Clinical Development and more. Amy Sullivan has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Amy Sullivan?
Find contact details for 700 million professionals.